NIS-793 (anti-TGFb1) 無載體, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191917-1MG / 1MG
CAS No.:2649854-92-0
NIS-793 (anti-TGFb1) 無載體, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191917-5MG / 5MG
CAS No.:2649854-92-0
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-100ΜG / 100ΜG
CAS No.:2427667-03-4
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-10MG / 10MG
CAS No.:2427667-03-4
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-1MG / 1MG
CAS No.:2427667-03-4
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-5MG / 5MG
CAS No.:2427667-03-4
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-100ΜG / 100ΜG
CAS No.:2428381-56-8
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-10MG / 10MG
CAS No.:2428381-56-8
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-1MG / 1MG
CAS No.:2428381-56-8
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-5MG / 5MG
CAS No.:2428381-56-8
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-100ΜG / 100ΜG
CAS No.:2428381-55-7
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-10MG / 10MG
CAS No.:2428381-55-7
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-1MG / 1MG
CAS No.:2428381-55-7
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-5MG / 5MG
CAS No.:2428381-55-7
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-100ΜG / 100ΜG
CAS No.:2304800-90-4
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-10MG / 10MG
CAS No.:2304800-90-4
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-1MG / 1MG
CAS No.:2304800-90-4
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-5MG / 5MG
CAS No.:2304800-90-4
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-100ΜG / 100ΜG
CAS No.:1826020-80-7
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-10MG / 10MG
CAS No.:1826020-80-7
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-1MG / 1MG
CAS No.:1826020-80-7
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-5MG / 5MG
CAS No.:1826020-80-7
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-100ΜG / 100ΜG
CAS No.:2210314-30-8
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-10MG / 10MG
CAS No.:2210314-30-8
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-1MG / 1MG
CAS No.:2210314-30-8
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-5MG / 5MG
CAS No.:2210314-30-8
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-100ΜG / 100ΜG
CAS No.:1796570-08-5
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-10MG / 10MG
CAS No.:1796570-08-5
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-1MG / 1MG
CAS No.:1796570-08-5
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-5MG / 5MG
CAS No.:1796570-08-5
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-100ΜG / 100ΜG
CAS No.:2382921-73-3
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-10MG / 10MG
CAS No.:2382921-73-3
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-1MG / 1MG
CAS No.:2382921-73-3
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-5MG / 5MG
CAS No.:2382921-73-3